頭頸部がん診断薬の世界市場レポート 2024年

頭頸部がん診断薬の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には16.7%の年間複合成長率（CAGR）で33億2,000万米ドルに成長すると予想されます。予測期間の成長は、ゲノムバイオマーカー、HPV関連がんの発生率の増加、人工知能（AI）の統合、免疫療法と標的療法の進歩、ヘルスケア政策と償還の変化などの要因に起因すると考えられます。予測期間の主な動向には、リキッドバイオプシーの優位性、マルチモダリティ診断の採用、ポイントオブケア診断の出現、世界の協力とパートナーシップ、デジタルパソロジーの統合が含まれます。

今後の頭頸部がん診断薬市場の成長は、頭頸部がんの発生率の増加によって牽引されると予想されます。このグループの腫瘍は、口、咽頭、喉頭、唾液腺、鼻腔、副鼻腔などの頭頸部領域のさまざまな組織や器官に影響を与えます。 頭頸部がん診断薬は、切開生検やバリウム嚥下検査などの検査による病気の早期発見に重要な役割を果たします。たとえば、2023年 2月、米国臨床腫瘍学会は、頭頸部がんが米国の全悪性腫瘍の4%を占め、2023年には推定66,920人が頭頸部がんに罹患すると予想されると報告しました。この罹患率は世界的に増加しており、オーストラリアでは、2022年に5,189人の新規感染者が発生しましたが、これが頭頸部がん診断薬市場の成長の主な原動力となっています。

個別化医療の採用の増加は、頭頸部がん診断薬市場の成長に貢献すると予想されます。個別化医療には、各患者の個別の特性に合わせて治療を調整し、治療結果を最適化し、副作用を最小限に抑えることが含まれます。頭頸部がんを効果的に管理するには、高精度の画像処理と個別のフォローアップケアが不可欠です。 2022年、食品医薬品局の医薬品評価研究センター（CDER）は37の新しい分子実体（NME）を承認し、そのうち約34％（12のNMEに相当）が個別化医療連合（PMC）によって個別化医療として分類されました。この個別化医療の採用は、頭頸部がん診断薬市場の成長を推進する重要な傾向を反映しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の頭頸部がん診断市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の頭頸部がん診断市場の規模実績と成長、2018年～2023年
• 世界の頭頸部がん診断市場の規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の頭頸部がん診断市場、診断方法別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 画像診断装置
• 内視鏡検査装置
• 生検スクリーニング検査
• 歯科診断方法
• その他の診断方法
• 世界の頭頸部がん診断市場、チャネル別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 小売店および専門薬局
• 病院薬局
• オンライン薬局
• 世界の頭頸部がん診断市場、エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 病院
• 診断センター
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の頭頸部がん診断市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
• 世界の頭頸部がん診断市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 頭頸部がん診断市場の競合情勢
• 頭頸部がん診断市場の企業プロファイル
  • F. Hoffmann-La Roche Ltd.
  • Bristol Myers Squibb Co.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • BioNTech AG

第31章 その他の大手・革新的企業

• Koninklijke Philips NV
• GE HealthCare Technologies Inc.
• Laboratory Corporation of America
• Agilent Technologies Inc.
• Hologic Inc.
• Illumina Inc.
• Shimadzu Corporation
• Sysmex Corp.
• Varian Medical Systems Inc.
• QIAGEN NV
• Exact Sciences Corp.
• Bio-Techne Corp.
• Carestream Health Inc.
• Myriad Genetics Inc.
• Cepheid Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Head and neck cancer diagnostics involve the identification and confirmation of malignant cells in the head and neck region through a combination of methods, including physical examination, imaging tests, medical history assessment, and tissue biopsy. This diagnostic process is commonly applied in the treatment of squamous cell carcinomas, laryngeal cancer, and hypopharyngeal cancer.

The primary methods employed in head and neck cancer diagnostics include diagnostic imaging equipment, endoscopy screening equipment, biopsy screening tests, dental diagnostic methods, and others. Diagnostic imaging equipment comprises various medical tools utilized to generate images of the internal organs and tissues for diagnostic purposes. These diagnostic processes involve multiple channels, including retail and specialty pharmacies, hospital pharmacies, and online pharmacies. The end-users benefiting from these diagnostic methods encompass hospitals, diagnostic centers, and others.

The head and neck cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides head and neck cancer diagnostics market statistics, including head and neck cancer diagnostics industry global market size, regional shares, competitors with a head and neck cancer diagnostics market share, detailed head and neck cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the head and neck cancer diagnostics industry. This head and neck cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The head and neck cancer diagnostics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 18.4%. The growth in the historical period can be attributed to factors such as tobacco and alcohol consumption, a rising aging population, awareness campaigns, developments in biopsy techniques, and improvements in healthcare infrastructure.

The head and neck cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to factors such as genomic biomarkers, an increasing incidence of HPV-related cancers, the integration of artificial intelligence (AI), advancements in immunotherapy and targeted therapies, and changes in healthcare policy and reimbursement. Major trends in the forecast period include the dominance of liquid biopsy, the adoption of multi-modality diagnostics, the emergence of point-of-care diagnostics, global collaborations and partnerships, and the integration of digital pathology.

The growth in the head and neck cancer diagnostics market in the future is expected to be driven by the increasing incidence of head and neck cancer. This group of tumors affects various tissues and organs in the head and neck region, including the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Head and neck cancer diagnostics play a crucial role in the early detection of the disease through tests such as incisional biopsy and barium swallow test. For example, in February 2023, the American Society of Clinical Oncology reported that head and neck cancer constituted 4% of all malignancies in the United States, with an estimated 66,920 people expected to be affected by it in 2023. This rise in incidence globally, such as in Australia, where there were 5,189 new cases in 2022, is a key driver for the growth of the head and neck cancer diagnostics market.

The increasing adoption of personalized medicines is expected to contribute to the growth of the head and neck cancer diagnostics market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, optimizing treatment outcomes, and minimizing side effects. Precision imaging and individualized follow-up care are crucial in managing head and neck cancers effectively. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and approximately 34% of these, equivalent to 12 NMEs, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This adoption of personalized medicine reflects a significant trend driving the growth of the head and neck cancer diagnostics market.

Product innovation is a prominent trend gaining traction in the head and neck cancer diagnostic market, with major players focusing on developing innovative products to strengthen their market position. For example, in May 2023, Alkem Laboratories Ltd., an India-based healthcare company, introduced Cetuxa, the world's first biosimilar for treating head and neck cancer. Cetuxa is a biosimilar to cetuximab, a monoclonal antibody with anti-tumor properties that inhibits the receptor-dependent transduction pathway. It binds to the extracellular domain of the epidermal growth factor receptor (EGFR). Clinical practice often combines cetuximab with chemotherapy or radiation therapy for treating locally advanced, recurring, or metastatic squamous cell carcinoma of the head and neck.

Major companies in the head and neck cancer diagnostics market are actively developing new products, such as antibodies, to gain a competitive advantage. Antibodies are proteins produced by the immune system in response to foreign substances. For instance, in February 2023, Roche Holding AG, a Switzerland-based pharmaceutical company, launched IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and ATRX Rabbit Polyclonal Antibody, offering advanced features in brain cancer diagnostics. These antibodies are specifically designed to detect mutations in the IDH1 and ATRX genes, providing clinicians with crucial diagnostic and prognostic information. The IDH1 antibody identifies the IDH1 R132H mutation in adult-type gliomas and acute myeloid leukemia (AML), aiding patient stratification for clinical trials. The ATRX antibody detects mutations in the ATRX gene, offering valuable insights for clinicians managing IDH-mutant gliomas.

In May 2022, Regeneron Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Checkmate Pharmaceuticals Inc. for an undisclosed amount. This acquisition is expected to enhance Regeneron Pharmaceuticals' position as a leader in immuno-oncology and expand its strategic adaptability and innovation with promising monotherapy and combination candidates for challenging malignancies. Checkmate Pharmaceuticals Inc., a US-based biopharmaceutical company, focuses on discovering and developing cancer immunotherapy approaches, including immuno-oncology treatments for head and neck cancer.

Major companies operating in the head and neck cancer diagnostics market report are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc., Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.

North America was the largest region in the head and neck cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the head and neck cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The head and neck cancer diagnostic market consists of revenues earned by entities by providing panoramic dental X-ray, magnetic resonance imaging (MRI), and computerized tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Head And Neck Cancer Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on head and neck cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for head and neck cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The head and neck cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Diagnostic Method: Diagnostic Imaging Equipment; Endoscopy Screening Equipment; Biopsy Screening Tests; Dental Diagnostic Methods; Other Diagnostic Methods
• 2) By Channel: Retail and Specialty Pharmacies; Hospital Pharmacies; Online Pharmacies
• 3) By End-User: Hospitals; Diagnostic Centers; Other End Users
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bristol Myers Squibb Co.; Abbott Laboratories; Siemens Healthineers AG; BioNTech AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Head And Neck Cancer Diagnostics Market Characteristics

3. Head And Neck Cancer Diagnostics Market Trends And Strategies

4. Head And Neck Cancer Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Head And Neck Cancer Diagnostics Market Size and Growth

• 5.1. Global Head And Neck Cancer Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Head And Neck Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Head And Neck Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Head And Neck Cancer Diagnostics Market Segmentation

• 6.1. Global Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diagnostic Imaging Equipment
• Endoscopy Screening Equipment
• Biopsy Screening Tests
• Dental Diagnostic Methods
• Other Diagnostic Methods
• 6.2. Global Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Retail and Specialty Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• 6.3. Global Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Other End Users

7. Head And Neck Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Head And Neck Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Head And Neck Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Head And Neck Cancer Diagnostics Market

• 8.1. Asia-Pacific Head And Neck Cancer Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Head And Neck Cancer Diagnostics Market

• 9.1. China Head And Neck Cancer Diagnostics Market Overview
• 9.2. China Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Head And Neck Cancer Diagnostics Market

• 10.1. India Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Head And Neck Cancer Diagnostics Market

• 11.1. Japan Head And Neck Cancer Diagnostics Market Overview
• 11.2. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Head And Neck Cancer Diagnostics Market

• 12.1. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Head And Neck Cancer Diagnostics Market

• 13.1. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Head And Neck Cancer Diagnostics Market

• 14.1. South Korea Head And Neck Cancer Diagnostics Market Overview
• 14.2. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Head And Neck Cancer Diagnostics Market

• 15.1. Western Europe Head And Neck Cancer Diagnostics Market Overview
• 15.2. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Head And Neck Cancer Diagnostics Market

• 16.1. UK Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Head And Neck Cancer Diagnostics Market

• 17.1. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Head And Neck Cancer Diagnostics Market

• 18.1. France Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Head And Neck Cancer Diagnostics Market

• 19.1. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Head And Neck Cancer Diagnostics Market

• 20.1. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Head And Neck Cancer Diagnostics Market

• 21.1. Eastern Europe Head And Neck Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Head And Neck Cancer Diagnostics Market

• 22.1. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Head And Neck Cancer Diagnostics Market

• 23.1. North America Head And Neck Cancer Diagnostics Market Overview
• 23.2. North America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Head And Neck Cancer Diagnostics Market

• 24.1. USA Head And Neck Cancer Diagnostics Market Overview
• 24.2. USA Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Head And Neck Cancer Diagnostics Market

• 25.1. Canada Head And Neck Cancer Diagnostics Market Overview
• 25.2. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Head And Neck Cancer Diagnostics Market

• 26.1. South America Head And Neck Cancer Diagnostics Market Overview
• 26.2. South America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Head And Neck Cancer Diagnostics Market

• 27.1. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Head And Neck Cancer Diagnostics Market

• 28.1. Middle East Head And Neck Cancer Diagnostics Market Overview
• 28.2. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Head And Neck Cancer Diagnostics Market

• 29.1. Africa Head And Neck Cancer Diagnostics Market Overview
• 29.2. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Head And Neck Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Head And Neck Cancer Diagnostics Market Competitive Landscape
• 30.2. Head And Neck Cancer Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bristol Myers Squibb Co.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Abbott Laboratories
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Siemens Healthineers AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. BioNTech AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Head And Neck Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Koninklijke Philips N.V.
• 31.2. GE HealthCare Technologies Inc.
• 31.3. Laboratory Corporation of America
• 31.4. Agilent Technologies Inc.
• 31.5. Hologic Inc.
• 31.6. Illumina Inc.
• 31.7. Shimadzu Corporation
• 31.8. Sysmex Corp.
• 31.9. Varian Medical Systems Inc.
• 31.10. QIAGEN N.V.
• 31.11. Exact Sciences Corp.
• 31.12. Bio-Techne Corp.
• 31.13. Carestream Health Inc.
• 31.14. Myriad Genetics Inc.
• 31.15. Cepheid Inc.

32. Global Head And Neck Cancer Diagnostics Market Competitive Benchmarking

33. Global Head And Neck Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Head And Neck Cancer Diagnostics Market

35. Head And Neck Cancer Diagnostics Market Future Outlook and Potential Analysis

• 35.1 Head And Neck Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Head And Neck Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Head And Neck Cancer Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer